Santander Consumer USA Holdings Inc. (SC - Free Report) announced second-quarter 2017 earnings of 70 cents per share, outpacing the Zacks Consensus Estimate of 62 cents. However, the bottom line declined 11.4% from 79 cents per share earned in the year-ago quarter.
Results were driven by higher revenues on the back of increased originations. However, an increase in costs, lower net finance and other income, and deteriorated credit quality perhaps disappointed investors. As a result, the stock lost 3.7% after the announcement.
Net income came in at $265 million, down 6.5% from the prior-year quarter. The company recorded a one-time tax benefit of $14 million, or 4 cents per share for the reported quarter.
Revenue Growth Partially Offset by Rise in Costs
Total revenue amounted to $1.69 billion, up 0.6% year over year.
Net finance and other interest income totaled $1.14 billion, down 5.3% year over year. The decline was primarily due to a combination of lower retail installment contract (RIC) balances and higher cost of funds stemming from a rise in benchmark rates.
Other income decreased by 35% from the prior-year quarter to $24.4 million.
Operating expenses increased 3.7% year over year to $282 million. Constant investment in compliance and control functions led to the rise.
As of Jun 30, 2017, net finance receivables, loans and leases were $35 billion, 3% higher than the Dec 31, 2016 figure. Further, total originations of $5.2 billion surged 6.6% from the prior-year quarter.
Credit Quality Weakens
Santander Consumer’s credit quality deteriorated in the quarter. Provision for credit losses increased 1.7% year over year to $521 million. Further, the total net charge-offs ratio increased from 6% to 7.5% for the quarter ended Jun 30, 2017. Also, end-of-period delinquency ratio was 4.7%, up from 4.2% in the year-ago period.
Capital and Profitability Ratios
As of Jun 30, 2017, Santander Consumer’s Common Equity Tier 1 capital ratio came in at 14.3%, rising from 12.6% as of Jun 30, 2016.
Return on average assets declined to 2.7% as of Jun 30, 2017 from 3% as of Jun 30, 2016. Also, return on average equity was down to 19.1% from 24% recorded in the year-ago quarter.
We believe that with the improvement in disposable income and consumer spending, Santander Consumer will primarily benefit from a rise in auto finance. However, a rise in provision for credit losses will restrict bottom-line growth.
Santander Consumer USA Holdings Inc. Price, Consensus and EPS Surprise
Currently, Santander Consumer carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.
Q2 Performance of Other Lenders
Capital One Financial Corporation’s (COF - Free Report) second-quarter 2017 adjusted earnings of $1.96 per share surpassed the Zacks Consensus Estimate of $1.90. Also, earnings compared favorably with $1.76 in the year-ago quarter.
The results were attributable to higher revenues and easing margin pressure. Also, the quarter witnessed a rise in loan balance. However, an increase in provisions and rising expenses acted as headwinds.
Sallie Mae (SLM - Free Report) reported second-quarter 2017 core earnings of 16 cents per share, in line with the Zacks Consensus Estimate. The bottom line however increased 33% from the prior-year quarter.
Earnings growth was supported by an increase in net interest income. The private education loan portfolio and deposits grew considerably. However, these positives were offset by lower non-interest income, higher expenses and a rise in provision for loan losses.
Ally Financial Inc.’s (ALLY - Free Report) second-quarter 2017 adjusted earnings of 58 cents per share surpassed the Zacks Consensus Estimate of 53 cents. Also, earnings increased 7.4% from the prior-year quarter.
Results benefited from an increase in total net revenues, partially offset by higher expenses. Capital ratios remained unchanged on a year-over-year basis in the quarter. However, higher provision for loan losses was a headwind.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>